Concert, Art Exhibit Celebrate End of Two-Week Arts Program for Individuals with Aphasia
June is Aphasia Awareness Month

Families, friends and members of the Lubbock community showed their support for the arts and those with aphasia at a June 12 concert and art exhibit marking the end of a two-week arts camp. The free event, held at the Texas Tech University Charles E. Maedgen Jr. Theatre, included performances and artwork by program participants.
The Summer Aphasia Arts Program is held by the Texas Tech University Health Sciences Center (TTUHSC) School of Health Professions Stroke and Aphasia Recovery (StAR) Program in partnership with the Texas Tech University J.T. & Margaret Talkington College of Visual & Performing Arts (TCVPA). The annual camp focuses on visual art, choir and drama for stroke and traumatic
brain injury survivors who have a type of communication challenge called aphasia.
It serves as a creative outlet for these individuals.
“The summer arts portion of the StAR Program is an intensive, summer program that runs the first two weeks of June,” Melinda Corwin, Ph.D., professor and assistant director, Department of Speech, Language and Hearing Sciences, said. “The program is for stroke survivors and people with primary progressive aphasia.”
Aphasia is a language disorder that affects the part of the brain responsible for
language. More than two million people in the U.S. are estimated to have aphasia and
have lost all or some ability to use words. It also affects their ability to understand
what others are saying to them, or to understand symbols of language on a page. The
person may have trouble reading, texting, typing or communicating via email. The condition
ranges from mild to severe and can happen to anyone who experiences a stroke, traumatic
brain injury, brain tumor or degenerative brain disease.
It does not affect intelligence.
“Typically, aphasia involves damage on the left side of the brain, which is our language center for spoken and written words,” Corwin said. “When we use the arts as a form of therapy, we’re tapping into the right side of the brain, and we’re using the right side to mediate or to help the damaged left side of the brain. We use visual arts and performing arts such as choir and drama, and we find that it really helps to promote language and communication.”
The summer arts camp is an extension of the StAR Program, an annual nine-month initiative that runs September through May.
Related Stories
Stay Safe: Preventing Summertime Dehydration
As the summer heat continues to intensify, so does the risk for dehydration. Prioritizing hydration this summer can protect you and your loved ones from potentially life-threatening complications.
Gov. Abbott Reappoints Varma to Texas Medical Board
Gov. Greg Abbott recently reappointed Surendra Varma, M.D., to the Texas Medical Board (TMB) District Three Review Committee.
Labor of Love: More Women Turn to Nurse-Midwives for Healthcare
In hospitals, birth centers and private homes across the country, nurse-midwives are expanding women’s healthcare options.
Recent Stories
Texas Tech University Health Sciences Center Announces Relocation and Expansion of the TTUHSC School of Nursing Mansfield Instructional Site
TTUHSC and the City of Mansfield announced a new collaboration to relocate and expand the School of Nursing’s existing Mansfield instructional site during the Mansfield City Council meeting on Monday, Aug. 24.
TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students
FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
